image
AN2 Therapeutics, Inc. ANTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.0
0 %
$ 29.8 M
Market Cap
-0.5
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -56.09% -64.77%
Annual Report FY 10-K 2022-12-31 0.00% -93.12% -95.89%
Annual Report FY 10-K 2021-12-31 0.00% -57.90% -196.18%
Annual Report FY 10-K 2020-12-31 0.00% -141.35% -40.67%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 23.70% 22.92%
Quarterly Report Q2 8-K 2024-06-30 0.00% 8.66% 4.34%
Quarterly Report Q1 8-K 2024-03-31 0.00% -13.76% -14.07%
Quarterly Report Q4 8-K 2023-12-31 0.00% -32.15% -50.81%
Quarterly Report Q3 8-K 2023-09-30 0.00% -53.16% -54.46%
Quarterly Report Q2 8-K 2023-06-30 0.00% -63.28% -60.66%
Quarterly Report Q1 8-K 2023-03-31 0.00% -92.20% -110.26%
Quarterly Report Q4 8-K 2022-12-31 0.00% -69.48% -64.29%
Quarterly Report Q3 8-K 2022-09-30 0.00% -57.11% -69.79%
Quarterly Report Q2 8-K 2022-06-30 0.00% -93.31% -106.74%
Quarterly Report Q1 8-K 2022-03-31 0.00% -271.09% -272.10%
Quarterly Report Q4 8-K 2021-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2021-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2021-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2021-03-31 0.00% 0.00% 0.00%